ArticleBreast cancer (Tokyo, Japan)2025
Polymorphous adenocarcinoma-like tumor of the breast: the first case report from Japan.
Article in Breast cancer (Tokyo, Japan), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Polymorphous adenocarcinoma-like (PmA-like) tumor of the breast is a rare salivary gland-like neoplasm, with few cases reported globally. We present the first case of a PmA-like tumor with a fibrous pseudocapsule from Japan, including radiological findings. A 40-year-old premenopausal woman presented with a painful mass in the right breast. Mammography revealed a high-density oval mass with predominantly circumscribed margins, while ultrasonography showed a hypoechoic oval mass with heterogeneous internal echoes and vascularity. Both imaging modalities suggested malignancy, prompting a vacuum-assisted biopsy. Histopathological evaluation demonstrated diverse growth patterns and positivity for cytokeratin (CK) 7 and Bcl-2. Initially diagnosed as an unusual ductal proliferation, malignancy could not be excluded, leading to lumpectomy. The resected tumor measured 26 mm, exhibited a fibrous pseudocapsule with focal disruption, and showed varied histological patterns, including solid, cribriform, glandular, and cord-like structures. Immunohistochemistry revealed expression of CK7, S100, vimentin, CK5/6, E-cadherin, Bcl-2, p63, and smooth muscle actin (SMA), with no expression of p40, estrogen receptor, progesterone receptor, HER2, c-Kit, or androgen receptor. These findings, including penetration beyond the capsule, supported the diagnosis of an invasive PmA-like tumor of the breast. Following surgery, the patient underwent additional resection and sentinel lymph node biopsy due to a positive margin. No residual tumor or nodal metastases were found. The patient declined adjuvant therapy and remains recurrence-free after 26 months of follow-up. PmA-like tumors of the breast present diagnostic challenges due to their rarity and diverse histopathological features. Further studies are necessary to characterize their clinical behavior and guide management strategies.
Indexed as
Identifiers
40319220What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.